Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation

Carbohydrate Polymers

Volumn 110, Issue , 2014, Pages 329-337

  Yao, Yashu ^a   Xie, Yan ^a   Hong, Chao ^a   Li, Guowen ^b   Shen, Hongyi ^a   Ji, Guang ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai TCM Integrated Hospital   (China)

Author keywords

Characterization; Hydroxypropyl cyclodextrin; In vitro dissolution; Inclusion complex; Myricetin; Pharmacokinetics

Indexed keywords

BIOCHEMISTRY; CHARACTERIZATION; CYCLODEXTRINS; DISSOLUTION; PHARMACOKINETICS; PLANTS (BOTANY); RATS; SOLUBILITY;

ANTI-OXIDANT ACTIVITIES; CYCLODEXTRIN INCLUSION COMPLEXES; IN-VITRO DISSOLUTION; INCLUSION COMPLEX; MYRICETIN; ORAL BIOAVAILABILITIES; PHARMACEUTICAL METHODS; PHARMACOLOGICAL ACTIVITY;

FLAVONOIDS;

2,2-DIPHENYL-1-PICRYLHYDRAZYL; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ANTIOXIDANT; BETA CYCLODEXTRIN DERIVATIVE; BIPHENYL DERIVATIVE; DRUG CARRIER; FLAVONOID; MYRICETIN; PICRIC ACID;

ANIMAL; BIOAVAILABILITY; CHEMISTRY; MALE; ORAL DRUG ADMINISTRATION; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; BIPHENYL COMPOUNDS; DRUG CARRIERS; FLAVONOIDS; MALE; PICRATES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84899800190     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.04.006     Document Type: Article

References (49)

1. K. Adibkia, M. Barzegar-Jalali, H. Maheri-Esfanjani, S. Ghanbarzadeh, J. Shokri, and A. Sabzevari et al. Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology Powder Technology 246 2013 448 455
2. L. Burton, W. Ying, R. Gandhi, R. West, C. Huang, and S. Zhou et al. Development of a precipitation-resistant solution formulation to increase in vivo exposure of a poorly water-soluble compound International Journal of Pharmaceutics 433 2012 94 101
3. S. Chakraborty, S. Basu, and S. Basak Effect of β-cyclodextrin on the molecular properties of myricetin upon nano-encapsulation: Insight from optical spectroscopy and quantum chemical studies Carbohydrate Polymers 99 2014 116 125
4. F. Dajas, F. Rivera, F. Blasina, F. Arredondo, C. Echeverry, and L. Lafon et al. Cell culture protection and in vivo neuroprotective capacity of flavonoids Neurotoxicity Research 5 2003 425 432
5. Y. Dang, G. Lin, Y. Xie, J. Duan, P. Ma, and G. Li et al. Quantitative determination of myricetin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its absolute bioavailability Drug Research 2013 10.1055/s-0033-1363220
6. M.R. de Freitas, L.A. Rolim, M.F.D. Soares, P.J. Rolim-Neto, M.M. de Albuquerque, and J.L. Soares-Sobrinho Inclusion complex of methyl-beta- cyclodextrin and olanzapine as potential drug delivery system for schizophrenia Carbohydrate Polymers 89 2012 1095 1100
7. A. Delrivo, A. Zoppi, and M.R. Longhi Interaction of sulfadiazine with cyclodextrins in aqueous solution and solid state Carbohydrate Polymers 87 2012 1980 1988
8. C.M. Fernandes, M.T. Vieira, and F.J. Veiga Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds European Journal of Pharmaceutical Sciences 15 2002 79 88
9. X. Ge, Z. Huang, S. Tian, Y. Huang, and C. Zeng Complexation of carbendazim with hydroxypropyl-beta-cyclodextrin to improve solubility and fungicidal activity Carbohydrate Polymers 89 2012 208 212
10. S. Gould, and R.C. Scott 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): A toxicology review Food and Chemical Toxicology 43 2005 1451 1459
11. M. Han, X. Yu, Y. Guo, Y. Wang, H. Kuang, and X. Wang Honokiol Nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system Colloids and Surfaces B: Biointerfaces 2014 10.1016/j.colsurfb.2013.12.056
12. T. Higuchi, and K.A. Connors Phase-solubility techniques Advances in Analytical Chemistry Instrumentation 4 1965 117 212
13. C. Jullian, L. Moyano, C. Yañez, and C. Olea-Azar Complexation of quercetin with three kinds of cyclodextrins: An antioxidant study Spectrochimica acta. Part A, Molecular and Biomolecular Spectroscopy 67 2007 230 234
14. S.W. Jun, M.S. Kim, J.S. Kim, H.J. Park, S. Lee, and J.S. Woo et al. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process European Journal of Pharmaceutics and Biopharmaceutics 66 2007 413 421
15. M. Kakran, N.G. Sahoo, and L. Li Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion Colloids and Surfaces B: Biointerfaces 88 2011 121 130
16. R. Kane, S. Naik, S. Bumrela, and B. Kuchekar Preparation, physicochemical characterization, dissolution and formulation studies of irbesartan cyclodextrin inclusion complexes: Comparison between β-CD & HP-β-CD Journal of Pharmacy Research 2 2009 1359 1364
17. H.Y. Kim, J.W. Choi, and S. Jung Inclusion complexes of modified cyclodextrins with some flavonols Journal of Inclusion Phenomena and Macrocyclic Chemistry 64 2009 43 47
18. M.K. Kim, K.S. Park, W.S. Yeo, H. Choo, and Y. Chong In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates Bioorganic & Medicinal Chemistry 17 2009 1164 1171
19. C.H. Ko, S.C. Shen, T.J. Lee, and Y.C. Chen Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells Molecular Cancer Therapeutics 4 2005 281 290
20. S.V. Kurkov, and T. Loftsson Cyclodextrins International Journal of Pharmaceutics 453 2013 167 180
21. Y.E. Kwon, H.M. Kim, S.Y. Park, and S.H. Jung Enhancement of solubility and antioxidant activity of some flavonoids based on the inclusion complexation with sulfobutylether β-cyclodextrin Bulletin of the Korean Chemical Society 31 2010 3035 3037
22. G. Li, X. Zeng, Y. Xie, Z. Cai, J.C. Moore, and X. Yuan et al. Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method Fitoterapia 83 2012 182 191
23. Y. Li, and Y. Ding Minireview: Therapeutic potential of myricetin in diabetes mellitus Food Science and Human Wellness 1 2012 19 25
24. I.M. Liu, T.F. Tzeng, S.S. Liou, and T.W. Lan Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats Life Sciences 81 2007 1479 1488
25. L. Lu, D. Qian, J. Guo, Y. Qian, B. Xu, and M. Sha et al. Abelmoschi Corolla non-flavonoid components altered the pharmacokinetic profile of its flavonoids in rat Journal of Ethnopharmacology 148 2013 804 811
26. C. Lucas-Abellán, M.T. Mercader-Ros, M.P. Zafrilla, J.A. Gabaldón, and E. Núñez-Delicado Comparative study of different methods to measure antioxidant activity of resveratrol in the presence of cyclodextrins Food and Chemical Toxicology 49 2011 1255 1260
27. S.X. Ma, W. Chen, X.D. Yang, N. Zhang, S.J. Wang, and L. Liu et al. Alpinetin/hydroxypropyl-beta-cyclodextrin host-guest system: Preparation, characterization, inclusion mode, solubilization and stability Journal of Pharmaceutical and Biomedical Analysis 67-68 2012 193 200
28. D.T. Maheshwari, M.S. Yogendra Kumar, S.K. Verma, V.K. Singh, and S.N. Singh Antioxidant and hepatoprotective activities of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves Food and Chemical Toxicology 49 2011 2422 2428
29. K. Miyake, H. Arima, F. Hirayama, M. Yamamoto, T. Horikawa, and H. Sumiyoshi et al. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-β-cyclodextrin Pharmaceutical Development and Technology 5 2000 399 407
30. T.A. Nguyen, B.G. Liu, J. Zhao, D.S. Thomas, and J.M. Hook An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex Food Chemistry 136 2013 186 192
31. K.C. Ong, and H.E. Khoo Biological effects of myricetin General Pharmacology 29 1997 121 126
32. H.Z. Ouyang, L. Fang, L. Zhu, L. Zhang, X.L. Ren, and J. He et al. Effect of external factors on the curcumin/2-hydroxypropyl-β-cyclodextrin: In vitro and in vivo study Journal of Inclusion Phenomena and Macrocyclic Chemistry 73 2011 423 433
33. V. Pandit, R. Gorantla, K. Devi, R.S. Pai, and S. Sarasija Preparation and characterization of pioglitazone cyclodextrin inclusion complexes Journal of Young Pharmacists 3 2011 267 274
34. P.A. Phillips, V. Sangwan, D. Borja-Cacho, V. Dudeja, S.M. Vickers, and A.K. Saluja Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway Cancer Letters 308 2011 181 188
35. M.N. Reddy, T. Rehana, S. Ramakrishna, K.P. Chowdhary, and P.V. Diwan Beta-cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studies AAPS PharmSciTech 6 2004 E7
36. N.G. Sahoo, M. Kakran, L.A. Shaal, L. Li, R.H. Muller, and M. Pal et al. Preparation and characterization of quercetin nanocrystals Journal of Pharmaceutical Sciences 100 2011 2379 2390
37. K. Sigfridsson, A.J. Lundqvist, and M. Strimfors Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development Drug Development and Industrial Pharmacy 35 2009 1479 1486
38. J.L. Soares-Sobrinho, F.L.A. Santos, M.A.M. Lyra, L.D.S. Alves, L.A. Rolim, and A.A.N. Lima et al. Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers Carbohydrate Polymers 89 2012 323 330
39. S. Stegemann, F. Leveiller, D. Franchi, H. de Jong, and H. Linden When poor solubility becomes an issue: From early stage to proof of concept European Journal of Pharmaceutical Sciences 31 2007 249 261
40. D. Villaño, M.S. Fernández-Pachón, M.L. Moyá, A.M. Troncoso, and M.C. García-Parrilla Radical scavenging ability of polyphenolic compounds towards DPPH free radical Talanta 71 2007 230 235
41. J.W. Wong, and K.H. Yuen Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins Drug Development and Industrial Pharmacy 29 2003 1035 1044
42. B. Yang, J. Lin, Y. Chen, and Y. Liu Artemether/hydroxypropyl-beta- cyclodextrin host-guest system: Characterization, phase-solubility and inclusion mode Bioorganic & Medicinal Chemistry 17 2009 6311 6317
43. L.J. Yang, S.X. Ma, S.Y. Zhou, W. Chen, M.W. Yuan, and Y.Q. Yin et al. Preparation and characterization of inclusion complexes of naringenin with beta-cyclodextrin or its derivative Carbohydrate Polymers 98 2013 861 869
44. Y. Yao, G. Lin, Y. Xie, P. Ma, G. Li, and Q. Meng et al. Preformulation studies of myricetin: A natural antioxidant flavonoid Die Pharmazie 69 2014 19 26
45. C. Yuan, L. Du, Z.Y. Jin, and X.M. Xu Storage stability and antioxidant activity of complex of astaxanthin with hydroxypropyl-beta-cyclodextrin Carbohydrate Polymers 91 2013 385 389
46. C. Yuan, Z.Y. Jin, and X. Xu Inclusion complex of astaxanthin with hydroxypropyl-beta-cyclodextrin: UV, FTIR, H-1 NMR and molecular modeling studies Carbohydrate Polymers 89 2012 492 496
47. J.J. Zhang, Y.T. Huang, D.P. Liu, Y. Gao, and S. Qian Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement European Journal of Pharmaceutical Sciences 48 2013 740 747
48. Y. Zheng, I.S. Haworth, Z. Zuo, M.S. Chow, and A.H. Chow Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes Journal of Pharmaceutical Sciences 94 2005 1079 1089
49. Q.N. Zhou, X.H. Wei, W. Dou, G.X. Chou, and Z.T. Wang Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins Carbohydrate Polymers 95 2013 733 739